With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting Aberrant Hh Signaling with BET Bromodomain Inhibition as a Novel Therapeutic Strategy Against MB and DIPG||Lucile Packard Children’s Hospital at Stanford University School of Medicine / Yujie Tang, PhD||Young Investigator Grants||2014||California|
|Identification of Resistance Mechanisms and Novel Therapeutic Strategies in Tyrosine Kinase Inhibitor Resistant FLT3/ITD Acute Myeloid Leukemia||Fred Hutchinson Cancer Research Center / Katherine Tarlock, MD||Young Investigator Grants||2014||Washington|
|Optimizing Engager T-cells for CD19+ Malignancies||Baylor College of Medicine / Mireya Paulina Velasquez, MD||Young Investigator Grants||2014||Texas|
|Hospital Volume and Induction Mortality in Children, Adolescents, and Young Adults with Acute Leukemia||Children’s Hospital of Philadelphia / Jennifer Wilkes, MD||Young Investigator Grants||2014||Pennsylvania|
|Development of Targeted Leukemia Inhibitors Using Nanoparticle Delivery||University of Massachusetts Medical School / Lucio Castilla, Ph.D.||Innovation Grants||2014||Massachusetts|
|Exploiting Epigenetic Dependencies of Notch1 for Clinical Benefit||University of Colorado Denver / Patricia Ernst, Ph.D.||Innovation Grants||2014||Colorado|
|Mechanisms and Targeted Inhibition of NT5C2 Mutations in Relapsed ALL||Columbia University / Adolfo A. Ferrando, M.D., Ph.D.||Innovation Grants||2014||New York|
|Targeting the Six1/Eya Transcriptional Complex to Inhibit Pediatric Sarcomas||University of Colorado Denver / Heide Ford, Ph.D.||Innovation Grants||2014||Colorado|
|Converting the Glioblastoma Multiforme Tumor-Associated Macrophage Phenotype||The Johns Hopkins University School of Medicine / Alan D. Friedman, M.D.||Innovation Grants||2014||Maryland|
|Targeting MYC/MYCN-driven Transcriptional Amplification in Pediatric Cancer||Dana-Farber Cancer Institute / Rani George, M.D., Ph.D.||Innovation Grants||2014||Massachusetts|